Rasu Shrestha has left his position as chief innovation officer at healthcare system University of Pittsburgh Medical Center (UPMC) to join another healthcare provider, Atrium Health, as chief strategy officer.
Having joined UPMC initially in 2007 as medical director of radiology informatics, Shrestha spent almost 12 years at the organisation and led its innovation strategy from 2014 as chief innovation officer in a bid to help serve patients in a more sustainable fashion.
Shrestha was concurrently an executive vice-president at UPMC’s investment arm, UPMC Enterprises, where he oversaw investments in startups focusing on healthcare intelligence.
UPMC Enterprises’ portfolio includes medical device manufacturer ALung Technologies, digital medicine prescription platform Xealth and remote care platform developer Vivify Health.
Shrestha’s chief strategy officer role will involve him reprising his previous position as executive vice-president. He will develop enterprise strategy and lead Atrium’s innovation efforts, making healthcare discoveries and technologies more accessible to its patients.
Shrestha said: “I am awestruck by the ambitions of Atrium Health to fulfil their mission to improve health, elevate hope and advance healing for all.
“I look forward to working with this incredibly talented team to forge ahead with meaningful strategies, partnerships and opportunities and to support this organisation’s commitment and dedication to its patients and communities.”
Photo of Rasu Shrestha courtesy of LinkedIn.
